Registry of Lobbyists
Total Number of Communication Reports: 5
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Economic Development, Foreign Affairs, Government Procurement, Health, Industry, International Relations, International Trade, National Security/Security, Science and Technology
|
Canadian-United States-Mexico Agreement (CUSMA) with respect to provisions relating to medical devices and technologies
|
Legislative Proposal, Bill or Resolution, Regulation, Policies or Program
|
|
Budget, Federal-Provincial Relations, Government Procurement, Health, Industry
|
Discuss policies around healthcare system resiliency, infection prevention, medication errors, women's health, and health equity
|
Regulation, Policies or Program
|
|
Economic Development, Federal-Provincial Relations, Government Procurement, Health, Industry, Science and Technology, Taxation and Finance
|
Federal budget with respect to medical technology and device innovation and adoption, support and delivery of new models of care, equitable healthcare access, women’s health, and investments in long-term care and home care
|
Legislative Proposal, Bill or Resolution
|
|
Economic Development, Government Procurement, Health, Industry, Science and Technology
|
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector
|
Policies or Program
|
|
Economic Development, Health, Industry, Research and Development, Science and Technology
|
Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes.
|
Policies or Program
|
|
Economic Development, Government Procurement, Health, Industry, International Trade, Research and Development, Science and Technology
|
Federal life sciences strategy with respect to global value chain and supply chain management and investment towards medical technology manufacturing and export.
|
Legislative Proposal, Bill or Resolution, Regulation, Policies or Program
|
|
Federal-Provincial Relations, Health, Industry
|
Federal life sciences strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and diagnostic testing.
|
Policies or Program
|
|
Health, Industry, Science and Technology
|
Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies
|
Regulation
|
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and increase access to care through new models of healthcare delivery.
Ivy Parks, President
Address:
2100 Derry Road West
Mississauga, ON L5N 0B3
Canada
Telephone number:
905-288-6000
Becton Dickinson Canada Inc does not have any subsidiaries that could have a direct interest in the outcome of the undertaking